Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Molecules (Basel, Switzerland)|June 28, 2023
Peripheralization Strategies Applied to Morphinans and Implications for Improved Treatment of PainHelmut Schmidhammer, Mahmoud Al-Khrasani, Susanna Fürst, et al.Life Sciences|April 23, 2004
Effect of novel non-peptidic delta opioid receptor antagonists on human T and B cell activationAntonella D'Ambrosio, Lia Noviello, Lucia Negri, et al.Frontiers in Pharmacology|September 21, 2018
In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in MiceRoberta Lattanzi, Silvia Rief, Helmut Schmidhammer, et al.Scientific Reports|February 19, 2016
μ Opioid receptor: novel antagonists and structural modelingTeresa Kaserer, Aquilino Lantero, Helmut Schmidhammer, et al.Journal of Medicinal Chemistry|November 9, 2012
Discovery and pharmacological evaluation of a diphenethylamine derivative (HS665), a highly potent and selective κ opioid receptor agonistMariana Spetea, Ilona P Berzetei-Gurske, Elena Guerrieri, et al.ACS Chemical Neuroscience|December 16, 2014
Synthesis and pharmacological evaluation of [(3)H]HS665, a novel, highly selective radioligand for the kappa opioid receptorElena Guerrieri, Jayapal Reddy Mallareddy, Géza Tóth, et al.International Journal of Molecular Sciences|November 14, 2020
Novel Positive Allosteric Modulators of µ Opioid Receptor-Insight from In Silico and In Vivo StudiesDamian Bartuzi, Ewa Kędzierska, Agnieszka A Kaczor, et al.Current Pharmaceutical Design|March 2, 2013
Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screeningMariana Spetea, Muhammad Faheem Asim, Stefan Noha, et al.Psychopharmacology|March 9, 2007
14-Methoxymetopon, a highly potent mu opioid agonist, biphasically affects ethanol intake in Sardinian alcohol-preferring ratsValentina Sabino, Pietro Cottone, Luca Steardo, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2010
In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor functionMariana Spetea, Catalina R Bohotin, Muhammad F Asim, et al.Pageof 6